Summary of Phase 1 Zoldonrasib Data at AACR 2026 ( Abstract # CT021 ) ...
Non-small cell lung cancer (NSCLC) remains a predominant cause of cancer-related mortality worldwide. In recent years, immune ...
NGS utilization increased over time but left substantial proportions untested across metastatic breast, prostate, pancreatic, ...
Background Sex-based differences in immune response are well established, but whether men and women derive comparable benefit ...
For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, ...
“I spent my entire career telling you about storms… Now I’m facing my own,” Nebraska meteorologist Kent Boughton said Vanessa Etienne is a Staff Writer for PEOPLE on the Health team. She joined the ...
Nebraska meteorologist Kent Boughton revealed that he was diagnosed with an aggressive and fast-growing type of cancer. On Friday, March 20, the beloved weatherman, 68, made the health admission in a ...
The KRAS p.G12D variant occurs in 5% of patients with non–small-cell lung cancer (NSCLC) and is the most common substitution variant in pancreatic ductal adenocarcinoma, occurring in 40% of patients, ...
"We are still learning how best to use immunotherapy in limited-stage, small-cell lung cancer. Concurrent immunotherapy with chemoradiotherapy did not improve survival, but we did not find worsened ...
SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...
HER2-mutated non-small-cell lung cancer (NSCLC) is a rare form of lung cancer where the cancer cells have a mutation that makes them grow and divide in an uncontrolled way. You can best understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results